Insiders · Profile

Angel Matthew

CEO and President at Tempest Therapeutics. Filing since 24 Mar 2026. CIK 0001931356

Company

Date

Role

Action

Shares

Amount

Of holding

TPST Tempest Therapeutics, Inc.

24 Mar 2026

CEO and President

Bought

462,964

$1.00M

opened

1 decision on file.